Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product & Services
3.2. Market Snippet by Type
3.3. Market Snippet by System
3.4. Market Snippet by Cancer Type
3.5. Market Snippet by Application
3.6. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Prevalence of Cancer
4.1.1.2. Growing Adoption of Particle Therapy in Clinical Trials
4.1.2. Restraints:
4.1.2.1. Affordability and Accessibility of Treatments
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product & Services
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services Segment
7.3. Market Attractiveness Index, By Product & Services Segment
7.3.1. Equipment*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Services
8. By Type
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
8.3. Market Attractiveness Index, By Type Segment
8.3.1. Proton Therapy*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Heavy Ion Therapy
9. By System
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System Segment
9.3. Market Attractiveness Index, By System Segment
9.3.1. Multi-Room System*
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.2. Single-Room System
10. By Cancer Type
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type Segment
10.3. Market Attractiveness Index, By Cancer Type Segment
10.3.1. Prostate Cancer*
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
10.3.2. Lung Cancer
10.3.3. Breast Cancer
10.3.4. Pediatric Cancer
10.3.5. Others (Head and Neck Cancer)
11. By Application
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3. Market Attractiveness Index, By Application
11.3.1. Treatment Application*
11.3.1.1. Introduction
11.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
11.3.2. Research Application
12. By Region
12.1. Introduction
12.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
12.3. Market Attractiveness Index, By Region
12.4. North America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. U.S.
12.4.8.2. Canada
12.4.8.3. Mexico
12.5. Europe
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. Germany
12.5.8.2. U.K.
12.5.8.3. France
12.5.8.4. Italy
12.5.8.5. Spain
12.5.8.6. Rest of Europe
12.6. South America
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.6.8.1. Brazil
12.6.8.2. Argentina
12.6.8.3. Rest of South America
12.7. Asia Pacific
12.7.1. Introduction
12.7.2. Key Region-Specific Dynamics
12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System
12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.7.8.1. China
12.7.8.2. India
12.7.8.3. Japan
12.7.8.4. Australia
12.7.8.5. Rest of Asia Pacific
12.8. Middle East and Africa
12.8.1. Introduction
12.8.2. Key Region-Specific Dynamics
12.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System
12.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
12.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.8.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Danfysik A/S*
14.1.1. Company Overview
14.1.2. Product & Services Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Advanced Oncotherapy PLC
14.3. Hitachi, Ltd.
14.4. Optivus Proton Therapy, Inc.
14.5. Mevion Medical Systems, Inc.
14.6. Provision Healthcare, LLC
14.7. Protom International, Inc.
14.8. Ion Beam Applications Sa (IBA)
14.9. Sumitomo Heavy Industries, Ltd.
14.10. Varian Medical Systems, Inc. (List Not Exhaustive)
15. Premium Insights
16. DataM Intelligence
16.1. Appendix
16.2. About Us and Services
16.3. Contact Us